Emalex Wins US Patent for Oral Ecopipam Formulation
09 Apr 2026 //
BUSINESSWIRE
First Patient Dosed In Emalex Biosciences` Expanded Access
09 Mar 2026 //
BUSSINESSWIRE
Emalex’s Lead Drug Hits Goals In Ph 3 Tourette Study
25 Feb 2025 //
BUSINESSWIRE
Emalex Biosciences Announces First Patient Dosed in Phase 3 Trial of Ecopipam
01 Mar 2023 //
PR NEWSWIRE

Market Place
Sourcing Support